Opening book details…
About this book
Proteome-wide Identification of Off-Targets of a Potent EGFRL858R/T790M Mutant Inhibitor by Peng Lyu, Kaili Jiang, Yuee Zhou, Jun Hu, Yu Chang, Zhang Zhang, Minhao Huang, Zhi-Min Zhang, Ke Ding, Piliang Hao, Ligen Lin & Zhengqiu Li is a book available to read on EtoBox.
- Author
- Peng Lyu, Kaili Jiang, Yuee Zhou, Jun Hu, Yu Chang, Zhang Zhang, Minhao Huang, Zhi-Min Zhang, Ke Ding, Piliang Hao, Ligen Lin & Zhengqiu Li
- Published
- 2022
- Language
- EN
More by Peng Lyu, Kaili Jiang, Yuee Zhou, Jun Hu, Yu Chang, Zhang Zhang, Minhao Huang, Zhi-Min Zhang, Ke Ding, Piliang Hao, Ligen Lin & Zhengqiu Li
Similar books
- Identification and In Silico Binding Study of a Highly Potent DENV NS2B-NS3 Covalent Inhibitor — Xincheng Lin, Jiawei Cheng, Yuming Wu, Yaoliang Zhang, Hailun Jiang, Jian Wang, Xuejun Wang & Maosheng Cheng (2022)
- Discovery and Preclinical Profiling of GSK3839919, a Potent HIV-1 Allosteric Integrase Inhibitor — Kyle Parcella, Tao Wang, Kyle Eastman, Zhongxing Zhang, Zhiwei Yin, Manoj Patel, Yong Tu, Barbara Zhizhen Zheng, Michael A. Walker, Mark G. Saulnier, David Frennesson, Michael Bowsher, Eric Gillis, Kevin Peese, Makonen Belema, Christopher Cianci, Ira... (2022)
- Conformational-Design-Driven Discovery of EZM0414: A Selective, Potent SETD2 Inhibitor for Clinical Studies — Joshua S. Alford, John W. Lampe, Dorothy Brach, Richard Chesworth, Kat Cosmopoulos, Kenneth W. Duncan, Sean T. Eckley, Jeffrey L. Kutok, Alejandra Raimondi, Thomas V. Riera, Brian Shook, Cuyue Tang, Jennifer Totman & Neil A. Farrow (2022)
- The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of Malaria — Manuel de Lera Ruiz, Paola Favuzza, Zhuyan Guo, Lianyun Zhao, Bin Hu, Zhiyu Lei, Dongmei Zhan, Nicholas Murgolo, Christopher W. Boyce, Marissa Vavrek, Jennifer Thompson, Anna Ngo, Kate E. Jarman, Johnathan Robbins, Justin Boddey, Brad E. Sleebs, Kym N.... (2022)
- NMR Backbone Assignment of VIM-2 and Identification of the Active Enantiomer of a Potential Inhibitor — Lianne H. E. Wieske, Jonathan Bogaerts, Albin A. M. Leding, Scott Wilcox, Anna Andersson Rasmussen, Kinga Leszczak, Lotta Turunen, Wouter A. Herrebout, Madlen Hubert, Annette Bayer & Máté Erdélyi (2022)
- Small-Molecule Inhibitor of the Oncogenic KRASG12C Mutant for the Treatment of Currently Incurable Cancer — Robert B. Kargbo (2022)